Lifecore Biomedical Provides Business Update
CHASKA, Minn., Dec. 13, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ:LFCR) (the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today provided a business update.
Related news for (LFCR)
- Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
- Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment Sale
- Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
- Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
- Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome